Monthly Communication Reports in:
October
2022
Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.
The list below is sorted by communication date, beginning with the most recent.
Heart and Stroke Foundation of Canada/Fondation des maladies du coeur et de l’AVC
Doug
Roth,
Chief Executive Officer
(Organization)
-
Heart and Stroke Foundation of Canada
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Michelle Bourdreau,
Executive Director
| Office of Pharmaceutical Management Strategies
|
Health Canada (HC)
-
Bobby Chauhan,
Director - Engagement
| Office of Pharmaceutical Management Strategies
|
Health Canada (HC)
-
Margaret Sharp,
Director - Pharmacy
| Office of Pharmaceutical Management Strategies
|
Health Canada (HC)
-
Jennifer Boutin,
Senior Policy Analyst
| Canada Drug Agency Transition Office
|
Health Canada (HC)
-
Brent Lawlor,
Acting Director
| Canada Drug Agency Transition Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-10-06
Posted date:
2022-11-15
Communication number:
119-546904
View associated registration